Radiation Oncology/Therapy: Page 56

FDA clears Perspectum's liver cancer decision tool

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared image analysis software developer Perspectum's Hepatica surgical decision-support tool for liver cancer.

January 27, 2021

Varian shows mixed results for Q1

By AuntMinnie.com staff writers

Radiation therapy firm Varian Medical Systems posted a 6% drop in revenue but higher net earnings for its first fiscal quarter of 2021.

January 26, 2021

Detectnet PET radiotracer gets permanent HCPCS code

By AuntMinnie.com staff writers

Biotechnology firm RadioMedix and nuclear medicine company Curium said that the U.S. Centers for Medicare and Medicaid Services has provided a permanent Healthcare Common Procedure Coding System (HCPCS) code for their Detectnet PET diagnostic radiopharmaceutical copper-64 DOTATATE.

January 25, 2021

Fuzionaire, NMP seek new PET radiopharmaceuticals

By AuntMinnie.com staff writers

Fuzionaire Radioisotope Technologies (FRIT) and radiopharmaceutical firm Nihon Medi-Physics (NMP) are teaming up in a bid to create a new class of PET radiopharmaceuticals.

January 25, 2021

Hypofractionated radiotherapy helped England survive COVID-19

By Emily Hayes

Greater use of hypofractionated dosing regimens helped radiation oncology sites deliver radiation therapy to cancer patients in England during the COVID-19 pandemic, offsetting a massive decline in treatment sessions overall, according to a study published January 22 in Lancet Oncology.

January 25, 2021

Canon's wide-bore CT for radiation therapy clears FDA

By AuntMinnie.com staff writers

The extra-wide-bore Aquilion Exceed LB CT scanner from Canon Medical Systems for applications in radiation therapy has been cleared by the U.S. Food and Drug Administration.

January 20, 2021

FDA commissioner Hahn leaves agency

By Brian Casey

Dr. Stephen Hahn, the commissioner of the U.S. Food and Drug Administration (FDA), has left the agency. He is being replaced on an interim basis by longtime FDA regulator Dr. Janet Woodcock.

January 19, 2021

Lantheus submits drug master file for imaging biomarker

By AuntMinnie.com staff writers

Lantheus Holdings, parent company of Lantheus Medical Imaging, said that it has filed a drug master file with the U.S. Food and Drug Administration for NM-01, a PD-L1 imaging biomarker for use in nuclear medicine.

January 11, 2021

Sun Nuclear's SunCheck nets more than 1,000 global users

By AuntMinnie.com staff writers

Radiation oncology quality-assurance technology developer Sun Nuclear has announced that its SunCheck quality management platform has netted more than 1,000 users in almost 60 countries.

January 10, 2021

ImaginAb, Pfizer ink deal on PET agent

By AuntMinnie.com staff writers

Imaging agent developer ImaginAb signed a multiyear, nonexclusive license with Pfizer to supply the zirconium-89 CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer patients.

January 7, 2021

RefleXion partners with HealthMyne on cancer radiomics

By AuntMinnie.com staff writers

Radiation therapy developer RefleXion Medical has signed a deal with HealthMyne to combine technologies to apply oncology radiomics to radiation therapy treatments.

January 7, 2021

Avacta inks license agreement with Point Biopharma

By AuntMinnie.com staff writers

Avacta Group has signed a license agreement with Point Biopharma to provide that company with access to its pre/Cision technology for developing tumor-activated radiopharmaceuticals.

January 6, 2021

Previous Page

Page 56 of 464

Next Page